PMGC Inc. (ELAB)
NASDAQ: ELAB
· Real-Time Price · USD
2.08
-0.09 (-4.15%)
At close: Jun 13, 2025, 3:59 PM
2.06
-0.96%
After-hours: Jun 13, 2025, 07:45 PM EDT
Company Description
PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of cutting-edge aesthetic medicines and therapeutic products.
The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists.
It is also involved in the medical scientific research and development activities, as well as operates investment firms.
The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024.
PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California.
PMGC Inc.
| Country | United States |
| IPO Date | Nov 21, 2023 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 2 |
| CEO | Graydon Bensler C.F.A. |
Contact Details
Address: 120 Newport Center Drive Newport Beach, California United States | |
| Website | https://pmgcholdings.com |
Stock Details
| Ticker Symbol | ELAB |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001840563 |
| CUSIP Number | n/a |
| ISIN Number | US73017P2011 |
| Employer ID | 85-1399981 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Graydon Bensler C.F.A. | Chief Executive Officer, Chief Financial Officer, Secretary & Director |
| Braeden William Lichti | Executive Chairman of the Board |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 09, 2025 | 8-K | Current Report |
| May 16, 2025 | 8-K | Current Report |
| May 15, 2025 | SCHEDULE 13G/A | [Amend] Filing |
| May 14, 2025 | 10-Q | Quarterly Report |
| May 13, 2025 | 8-K | Current Report |
| May 01, 2025 | 8-K | Current Report |
| Apr 24, 2025 | 8-K | Current Report |
| Apr 24, 2025 | 8-K | Current Report |
| Apr 24, 2025 | 424B5 | Filing |
| Apr 17, 2025 | 8-K | Current Report |